ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Exsiccated Disodium Phosphate

Also known as: Disodium phosphate (anhydrous, exsiccated), Sodium phosphate dibasic, Exsiccated sodium phosphate, Na₂HPO₄ (anhydrous form), Disodium Phosphate

Overview

Disodium phosphate is an inorganic salt widely used as a buffering agent, emulsifier, sequestrant, and mineral supplement. It is synthesized for industrial, pharmaceutical, and food applications. As a supplement, it is primarily used to address phosphate deficiencies under medical supervision. It appears as a white, crystalline, water-soluble powder and functions as a pH stabilizer and a source of phosphate ions. Research on disodium phosphate is mature in the context of food safety and medical applications, particularly in managing phosphate levels in individuals with chronic kidney disease. However, there is limited high-quality clinical trial data supporting its use as a general supplement in healthy populations. The available evidence suggests that its benefits are mainly confined to clinical populations with specific phosphate imbalances.

Benefits

The primary benefit of disodium phosphate is its ability to reduce serum and urinary phosphate levels in clinical populations, such as individuals with chronic kidney disease (CKD). Studies show that phosphate binders, including disodium phosphate analogs, can effectively lower phosphate levels, although the impact on long-term clinical outcomes like cardiovascular events and mortality remains unclear. In CKD, noncalcium-based phosphate binders have been shown to reduce serum phosphate by approximately 0.3–0.5 mg/dL. It is also used to maintain phosphate balance in deficiency states. There is a lack of robust evidence supporting performance or health benefits in healthy adults. Its use should be limited to individuals with diagnosed hypophosphatemia or those requiring phosphate supplementation for specific medical reasons.

How it works

Disodium phosphate provides bioavailable phosphate ions, which are essential for various physiological processes. These ions play a crucial role in bone mineralization, energy metabolism through ATP production, and cellular signaling pathways. It primarily affects mineral metabolism, bone health, and renal phosphate handling. The phosphate ions are absorbed from the gastrointestinal tract via phosphate transporters and are regulated by the kidneys, which excrete excess phosphate. It interacts with calcium-phosphate homeostasis, influencing bone density and overall mineral balance in the body.

Side effects

Disodium phosphate is generally recognized as safe (GRAS) when used as a food additive. However, medical use at high doses can lead to adverse effects. Common side effects include gastrointestinal upset, such as nausea and diarrhea, particularly in sensitive individuals or at elevated doses. Uncommon side effects may include mild eye or skin irritation upon direct contact. Rare but severe side effects include phosphate toxicity, potentially leading to hyperphosphatemia, hypocalcemia, and tetany, especially with excessive intake. It may interact with medications affecting phosphate or calcium balance, such as diuretics and phosphate binders. It is contraindicated in individuals with hyperphosphatemia or severe renal impairment. Caution is advised for individuals with kidney disease or those at risk for hyperphosphatemia.

Dosage

For supplementation, a typical dosage range is 250–500 mg of elemental phosphorus (as phosphate) per dose, administered 1–3 times daily, as needed for deficiency under medical supervision. The upper safe limit is not well-defined for healthy adults, and exceeding 4,000 mg of phosphorus per day should be avoided unless medically supervised. It can be taken with or without food, as absorption is not significantly affected by timing. The exsiccated (anhydrous) form is more concentrated than hydrated forms, requiring dosage adjustments accordingly. Absorption can be reduced by concurrent intake of calcium, magnesium, or aluminum-containing products. Adequate vitamin D status supports phosphate utilization.

FAQs

Is disodium phosphate recommended for routine supplementation in healthy adults?

No, it is not recommended for routine supplementation in healthy adults. Its use should be reserved for individuals with diagnosed phosphate deficiencies and administered under medical supervision.

Is disodium phosphate safe?

It is generally safe at levels used as a food additive. However, high doses can lead to phosphate toxicity, including hyperphosphatemia and related complications. Medical supervision is essential for supplementation.

When should I take disodium phosphate?

It can be taken at any time, with or without food. There are no specific timing requirements, but concurrent intake of calcium, magnesium, or aluminum-containing products may reduce absorption.

What are the expected results of taking disodium phosphate?

In individuals with phosphate deficiency, the expected result is normalization of serum phosphate levels. Healthy individuals are unlikely to experience any benefits, and supplementation is not advised.

Is disodium phosphate a performance enhancer?

No, it is not a performance enhancer or a general health supplement for healthy adults. Its primary use is in managing phosphate deficiencies under medical supervision.

Research Sources

  • https://pubmed.ncbi.nlm.nih.gov/34645696/ – This systematic review and meta-analysis of RCTs examined the effects of noncalcium-based phosphate-lowering therapy in adults with chronic kidney disease. The study found that these therapies, including disodium phosphate analogs, reduced serum and urinary phosphate levels. However, the effects on patient-centered clinical outcomes were unclear, highlighting the need for adequately powered RCTs to assess these outcomes.
  • https://pubchem.ncbi.nlm.nih.gov/compound/Sodium-Phosphate_-Dibasic – This entry from PubChem provides comprehensive chemical and safety information on disodium phosphate. It details the compound's structure, properties, and potential hazards, including irritation and toxicity at high doses. This information is crucial for understanding the safe handling and use of disodium phosphate in various applications.
  • https://www.ams.usda.gov/sites/default/files/media/SAP%201%20report.pdf – This document from the USDA likely discusses the use of disodium phosphate in food processing and its safety as a food additive. It provides insights into the regulatory aspects and acceptable levels of disodium phosphate in food products. The report contributes to understanding the broader context of disodium phosphate use beyond supplementation.
  • https://datasheets.scbt.com/sc-203277.pdf – This material safety data sheet from Santa Cruz Biotechnology provides detailed safety information on disodium phosphate. It outlines potential hazards, handling precautions, and first aid measures in case of exposure. The datasheet is a reliable source for hazard identification and safe laboratory practices when working with disodium phosphate.
  • https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2016.00992/full – This in vitro study investigated the effects of disodium phosphate on E. coli growth and Shiga toxin production. The findings indicated that disodium phosphate did not significantly affect E. coli growth or Shiga toxin production at typical food additive concentrations. While the study is limited by its in vitro model, it provides insights into the microbiological safety of disodium phosphate in food applications.